The National Pharmaceutical Council eNewsletter featured findings from a HCFO-funded study led by Niteesh K. Choudhry, M.D., Ph.D., Harvard Medical School and Brigham and Women’s Hospital. In their recent article in Health Affairs , Choudhry and colleagues identified five key features of value-based insurance design (VBID) plans that are associated with greater medication adherence among patients.
Links:
[1] http://www.npcnow.org/newsletter/content/medication-adherence-lessons-under-vbid
[2] http://www.hcfo.org/grants/factors-influencing-success-value-based-insurance-design-programs
[3] http://www.hcfo.org/publications/five-features-value-based-insurance-design-plans-were-associated-higher-rates-medicatio
[4] http://www.hcfo.org/topics/benefit-design
[5] http://www.hcfo.org/topics/consumer-behavior
[6] http://www.hcfo.org/topics/insurance-coverage
[7] http://www.hcfo.org/topics/prescription-drugs